Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Open accessThe DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, affect several million individuals worldwide. Crohn’s disease and ulcerative colitis are complex diseases that are heterogeneous at the clinical, immunological, molecular, genetic, and microbial levels. Individual contributing factors have been the focus of extensive research. As part of the Integrative Human Microbiome Project (HMP2 or iHMP), we followed 132 subjects for one year each to generate integrated longitudinal molecular profiles of host and microbial activity during disease (up to 24 time points each; in total 2,965 stool, biopsy, and blood specimens). Here we present the results, which provide a comprehensive view of functional dysbiosis in the gut microbiome during inflammatory bowel disease activity. We demonstrate a characteristic increase in facultative anaerobes at the expense of obligate anaerobes, as well as molecular disruptions in microbial transcription (for example, among clostridia), metabolite pools (acylcarnitines, bile acids, and short-chain fatty acids), and levels of antibodies in host serum. Periods of disease activity were also marked by increases in temporal variability, with characteristic taxonomic, functional, and biochemical shifts. Finally, integrative analysis identified microbial, biochemical, and host factors central to this dysregulation. The study’s infrastructure resources, results, and data, which are available through the Inflammatory Bowel Disease Multi’omics Database ( http://ibdmdb.org ), provide the most comprehensive description to date of host and microbial activities in inflammatory bowel diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This relative absence of biomarkers for active UC may result both from its generally more benign phenotype (IBDMDB Investigators et al., 2019) and from the smaller number of active UC samples (n = 23) compared with active CD samples (n = 76); as a result, we focused our subsequent analyses on expression differences within the CD subcohort.”
From Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3 (2021) · cites this paper as IBDMDB Investigators et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This network of mechanistic associations identified several key components that are central to the alterations seen in IBD, highlighting octanoyl carnitine, several lipids and short-chain fatty acids, the taxa Faecalibacterium, Subdoligranulum, Roseburia, Alistipes, and Escherichia, some at both the metagenomic and metatranscriptomic levels, and host regulators of interleukins49.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Multiple lines of evidence point towards central roles of gut microbiome perturbations in the pathogenesis of IBD.”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [152]
The cited source says what the claim attributes to it.
In the citing paper
“These studies, which have now reached the first stage of completion49–51, together provide a wealth of information and insights about not only microbial dynamics, but also associated human host responses and microbial inter-relationships.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
In the citing paper
“The authors could then use the 17 top taxa in their ranked list to identify which individuals are dysbiotic, an approach that demonstrated similar or better performance than the GMWI2 or another published metric called the “dysbiotic score”.195”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [195]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4 · Cited by 33,115
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
Self-citationUPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,707
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Fast and sensitive protein alignment using DIAMOND
Buchfink, B., Xie, C., & Huson, D. H. (2015) · Nature Methods · doi:10.1038/nmeth.3176 · Cited by 14,201
Cited by
Items 401–500 of 1,010
MAGScoT : a fast, lightweight and accurate bin-refinement tool
Rühlemann, M. C., Wacker, E. M., Ellinghaus, D., & Franke, A. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac694 · Cited by 80
Unraveling the Role of the Human Gut Microbiome in Health and Diseases
Khalil, M., Ciaula, A. D., Mahdi, L., Jaber, N., Palo, D. M. D., Graziani, A., Baffy, G., & Portincasa, P. (2024) · Microorganisms · doi:10.3390/microorganisms12112333 · Cited by 114
“In many respects, IBD is a type of gut microbiome-associated disease characterized by dysbiosis [366], reduced species richness and diversity, and lower temporal stability [367].”
Gut microbiota mediated T cells regulation and autoimmune diseases
Bhutta, N. K., Xu, X., Jian, C., Wang, Y., Liu, Y., Sun, J., Han, B., Wu, S., & Javeed, A. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1477187 · Cited by 82
Lloréns-Rico, V., Vieira-Silva, S., Gonçalves, P. J., Falony, G., & Raes, J. (2021) · Nature Communications · doi:10.1038/s41467-021-23821-6 · Cited by 73
Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis
Huh, J., & Roh, T. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01887-4 · Cited by 87
Qiu, X., Zhao, X., Cui, X., Mao, X., Tang, N., Jiao, C., Wang, D., Zhang, Y., Ye, Z., & Zhang, H. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820971202 · Cited by 83
Barber, C., Mego, M., Sabater, C., Vallejo, F., Bendezu, R. A., Masihy, M., Guarner, F., Espín, J. C., Margollés, A., & Azpiroz, F. (2021) · Nutrients · doi:10.3390/nu13082638 · Cited by 86
“edu/halla last accessed on 19 November 2020) [32].”
BackgroundRajakovich, L. J., Fu, B., Bollenbach, M., & Balskus, E. P. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2101498118 · Cited by 87
“Next, we examined three cohorts with corresponding stool metabolomics data [HMP2 (38), BIO-ML (42), and PRISM (43)] to evaluate whether the presence of bbuA gene or transcripts is associated with changes in metabolite levels.”
BackgroundMethodInfluentialMicrobiome as an immune regulator in health, disease, and therapeutics
Juarez, V. M., Montalbine, A. N., & Singh, A. K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114400 · Cited by 79
The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease
Ocansey, D. K. W., Hang, S., Yuan, X., Qian, H., Zhou, M., Olovo, C. V., Zhang, X., & Mao, F. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2176118 · Cited by 75
Microbiota and IBD: Current knowledge and future perspectives
Foppa, C., Rizkala, T., Repici, A., Hassan, C., & Spinelli, A. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.11.015 · Cited by 94
BilR is a gut microbial enzyme that reduces bilirubin to urobilinogen
Hall, B., Levy, S., Dufault‐Thompson, K., Arp, G., Zhong, A., Ndjite, G. M., Weiss, A., Braccia, D. J., Jenkins, C., Grant, M. R., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01549-x · Cited by 111
“Compared with healthy adults, patients with IBD have been observed to have lower levels of urobilin and have been observed to form pigmented gallstones containing high levels of bilirubin 25,26 .”
BackgroundViroid-like colonists of human microbiomes
Zheludev, I. N., Edgar, R. C., Lopez-Galiano, M. J., de la Peña, M., Babaian, A., Bhatt, A. S., & Fire, A. Z. (2024) · Cell · doi:10.1016/j.cell.2024.09.033 · Cited by 73
Viroid-like colonists of human microbiomes
Zheludev, I. N., Edgar, R. C., Lopez-Galiano, M. J., de la Peña, M., Babaian, A., Bhatt, A. S., & Fire, A. Z. (2024) · doi:10.1101/2024.01.20.576352 · Cited by 73
“We initially applied VNom to published Integrative Human Microbiome Project (iHMP) data 20 resulting in the identification of a new class of hGMB-colonising RNA agents, which we term ‘Obelisks’.”
InfluentialThe microbiome in rheumatology: Where are we and where should we go?
Manasson, J., Blank, R. B., & Scher, J. U. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216631 · Cited by 79
Chen, D., Chen, G., Chen, C., Zeng, X., & Ye, H. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.04.248 · Cited by 73
Investigation of Spaceflight Induced Changes to Astronaut Microbiomes
Morrison, M. D., Thissen, J. B., Karouia, F., Mehta, S. K., Urbaniak, C., Venkateswaran, K. J., Smith, D. J., & Jaing, C. J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.659179 · Cited by 80
“Air and surface samples from the Apollo and Skylab spacecraft were also collected to monitor cultivable microbial cross-over from the crew and screen for pathogens (Johnston et al., 1975; Johnson and Dietlein, 1977).”
BackgroundMethodA meta-analysis study of the robustness and universality of gut microbiome-metabolome associations
Muller, E., Algavi, Y. M., & Borenstein, E. (2021) · Microbiome · doi:10.1186/s40168-021-01149-z · Cited by 85
“iHMP_IBD [iH] [19] 72 [26] 212 [79] (IBD) WGSS Untargeted, MS 504”
den Hartigh, L. J., May, K. S., Zhang, X., Chait, A., & Blaser, M. J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1197432 · Cited by 95
Expanding the human gut microbiome atlas of Africa
Maghini, D. G., Oduaran, O. H., Ingasia, L. A. O., Cook, J. A., Smyth, N., Mathema, T., Belger, C. W., Agongo, G., Boua, P. R., Choma, S., et al. (2025) · Nature · doi:10.1038/s41586-024-08485-8 · Cited by 96
“We generated a viral genome catalogue from all metagenomic assemblies and clustered all genomes at 95% ANI (Supplementary Data 7).”
Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease
Caër, C., & Wick, M. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00410 · Cited by 78
Zhao, H., Xu, H., Chen, S., He, J., Zhou, Y., & Nie, Y. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15222 · Cited by 83
Statistical approaches for differential expression analysis in metatranscriptomics
Zhang, Y., Thompson, K. N., Huttenhower, C., & Franzosa, E. A. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab327 · Cited by 84
Self-citationShaffer, J. P., Carpenter, C. S., Martino, C., Salido, R. A., Minich, J. J., Bryant, M., Sanders, K., Schwartz, T., Humphrey, G., Swafford, A. D.-E., et al. (2022) · BioTechniques · doi:10.2144/btn-2022-0032 · Cited by 84
Self-citationProbiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches
Štofilová, J., Kvaková, M., Kamlárová, A., Hijová, E., Bertková, I., & Guľašová, Z. (2022) · Biomedicines · doi:10.3390/biomedicines10092236 · Cited by 81
“The proliferation of some species at the expense of others may lead to a change of metabolism function and a different profile of microbial metabolites, such as changes in short-chain fatty acids (SCFA) and tryptophan levels, as confirmed in both UC and CD patients [11,16,17].”
ResultSmoking-induced microbial dysbiosis in health and disease
Shapiro, H., Goldenberg, K., Ratiner, K., & Elinav, E. (2022) · Clinical Science · doi:10.1042/cs20220175 · Cited by 82
Spiga, L., Fansler, R. T., Perera, Y. R., Shealy, N. G., Munneke, M. J., David, H. E., Torres, T. P., Lemoff, A. S., Ran, X., Richardson, K. L., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.08.018 · Cited by 78
Challenges and opportunities in sharing microbiome data and analyses
Huttenhower, C., Finn, R. D., & McHardy, A. C. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01484-x · Cited by 78
“…for each of these examples, successful integrative case studies include the use of clinical data in combination with ex vivo microbiology to characterize drug interactions in the Human Microbiome Project 16,66 or the assessment of gut microbial chemistry of diet in humans and gnotobiotic mice 67 .”
BackgroundSelf-citationWan, L., Qian, C., Yang, C., Peng, S., Dong, G., Cheng, P., Zong, G., Han, H., Shao, M., Gong, G., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130822 · Cited by 80
Han, H. S., Hwang, S., Choi, K. Y., Hitayezu, E., Mabwi, H. A., Enkhbayar, A., Song, D., Kim, M., Park, J. S., Park, Y., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12487 · Cited by 81
“We analyzed bacterial communities in 1,638 stool samples from 130 participants in the Integrative Human Microbiome Project (HMP2) (Lloyd-Price et al., 2019) (Table S1).”
MethodInfluentialMa, C., Wasti, S., Huang, S. W., Zhang, Z., Mishra, R., Jiang, S., You, Z., Wu, Y., Chang, H., Wang, Y., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1785252 · Cited by 81
“observed in patients suffering from acute myeloid leukemia.(29,30) The probiotics are commonly found to cause mild diarrhea in the early consumption stage.”
BackgroundKeller, L. J., Babin, B. M., Lakemeyer, M., & Bogyo, M. S. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.10.007 · Cited by 78
Wang, Z., Liu, H., Wang, F., Yang, Y., Wang, X., Chen, B., Stämpfli, M. R., Zhou, H., Shu, W., Brightling, C. E., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01758 · Cited by 76
Liu, M., Devlin, J. C., Hu, J., Volkova, A., Battaglia, T., Ho, M. L., Asplin, J. R., Byrd, A. L., Loke, P., Li, H., et al. (2021) · eLife · doi:10.7554/elife.63642 · Cited by 82
“Metagenomic and metatranscriptomic data of healthy humans and IBD subjects were collected from the iHMP-IBD study (Lloyd-Price et al., 2019).”
MethodDynamic Bayesian Networks for Integrating Multi-omics Time Series Microbiome Data
Ruiz-Perez, D., Lugo-Martinez, J., Bourguignon, N., Mathee, K., Lerner, B., Bar‐Joseph, Z., & Narasimhan, G. (2021) · mSystems · doi:10.1128/msystems.01105-20 · Cited by 76
“The cohort included 132 individuals across five clinical centers [14].”
BackgroundThe role of fecal sulfur metabolome in inflammatory bowel diseases
Walker, A., & Schmitt‐Kopplin, P. (2021) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2021.151513 · Cited by 74
Serrano-Gómez, G., Mayorga, L., Oyarzun, I., Roca, J., Borruel, N., Casellas, F., Varela, E., Pozuelo, M., Machiels, K., Guarner, F., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.11.037 · Cited by 82
“This dysbiosis is characterized by reduced microbial diversity, a shift in the abundance of Firmicutes phylum bacteria towards Proteobacteria [7–9], and disruption of metabolites, including acylcarnitines, bile acids, and short-chain fatty acids (SCFAs) [10].”
BackgroundMethodResultInfluentialLin, X., Hu, T., Wu, Z., Li, L., Wang, Y., Wen, D., Liu, X., Li, W., Liang, H., Jin, X., et al. (2024) · iMeta · doi:10.1002/imt2.174 · Cited by 78
Nagayama, M., Yano, T., Atarashi, K., Tanoue, T., Sekiya, M., Kobayashi, Y., Sakamoto, H., Miura, K., Sunada, K., Kawaguchi, T., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1788898 · Cited by 78
“gnavus is reportedly increased in CD, thereby being implicated in its pathogenesis.(27) R.”
BackgroundElucidation of Gut Microbiota-Associated Lipids Using LC-MS/MS and 16S rRNA Sequence Analyses
Yasuda, S., Okahashi, N., Tsugawa, H., Ogata, Y., Ikeda, K., Suda, W., Arai, H., Hattori, M., & Arita, M. (2020) · iScience · doi:10.1016/j.isci.2020.101841 · Cited by 76
“Genetic and environmental factors induce microbial imbalance called dysbiosis, which causes various diseases, including inflammatory bowel disease (IBD), diabetes, rheumatoid arthritis, and autism (Wang et al., 2011, 2015; Hsiao et al., 2013; Yoshimoto et al., 2013; Kim et al., 2014; Becattini et al., 2016; Pedersen e…”
BackgroundTorres, J., Halfvarson, J., Rodríguez–Lago, I., Hedin, C. R. H., Jess, T., Dubinsky, M. C., Croitoru, K., & Colombel, J. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab048 · Cited by 76
Voisine, J., & Abadie, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.674313 · Cited by 87
Jang, H., Kim, J.-K., Joo, M.-K., Shin, Y.-J., Lee, C. K., Kim, H. J., & Kim, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-00088-x · Cited by 78
Yang, Y., Zheng, X., Wang, Y., Tan, X., Zou, H., Feng, S., Zhang, H., Zhang, Z., He, J., Cui, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.836542 · Cited by 88
“Nicotinuric acid was significantly enriched in the feces of mice in the UC+DSS group, and while it was found to be almost exclusively present in the feces of patients with IBD (44), the cause of nicotinic acid enrichment needs to be investigated.”
BackgroundPathogenic associations between oral and gastrointestinal diseases
Newman, K. L., & Kamada, N. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.05.006 · Cited by 75
Investigating differential abundance methods in microbiome data: A benchmark study
Cappellato, M., Baruzzo, G., & Camillo, B. D. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010467 · Cited by 80
“Parameters in group A are estimated from three different real datasets [37–40] representing different biological and technical scenarios (Table 2 and Section 4 in S1 File).”
MethodRole of Hydrogen Sulfide in Inflammatory Bowel Disease
Stummer, N., Feichtinger, R. G., Weghuber, D., Kofler, B., & Schneider, A.-M. (2023) · Antioxidants · doi:10.3390/antiox12081570 · Cited by 82
Simpson, J. B., Walker, M. E., Sekela, J. J., Ivey, S. M., Jariwala, P. B., Storch, C. M., Kowalewski, M. E., Graboski, A. L., Lietzan, A. D., Walton, W. G., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.04.018 · Cited by 78
Akiyama, S., Nishijima, S., Kojima, Y., Kimura, M., Ohsugi, M., Ueki, K., Mizokami, M., Hattori, M., Tsuchiya, K., Uemura, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54797-8 · Cited by 87
Le, V., Quinn, T. P., Tran, T., & Venkatesh, S. (2020) · BMC Genomics · doi:10.1186/s12864-020-6652-7 · Cited by 82
Kong, L., Lloyd-Price, J., Vatanen, T., Seksik, P., Beaugerie, L., Simon, T., Vlamakis, H., Sokol, H., & Xavier, R. J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.045 · Cited by 69
Self-citationXu, W. L., Lin, J., Gao, M. Y., Chen, Y., Cao, J., Pu, J., Huang, L., Zhao, J., & Qian, K. (2020) · Advanced Science · doi:10.1002/advs.202002021 · Cited by 69
The infant gut resistome is associated with E. coli and early-life exposures
Lebeaux, R. M., Coker, M. O., Dade, E. F., Palys, T. J., Morrison, H. G., Ross, B. D., Baker, E. R., Karagas, M. R., Madan, J. C., & Hoen, A. G. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02129-x · Cited by 68
“Interindividual differences were analyzed as it often accounts for the largest amount of variation in microbiome studies [20,29,58].”
BackgroundElhenawy, W., Hordienko, S., Gould, S., Oberc, A. M., Tsai, C. N., Hubbard, T. P., Waldor, M. K., & Coombes, B. K. (2021) · Nature Communications · doi:10.1038/s41467-021-22306-w · Cited by 75
Associations between the gut microbiome and metabolome in early life
Nguyen, Q. P., Karagas, M. R., Madan, J. C., Dade, E. F., Palys, T. J., Morrison, H. G., Pathmasiri, W., McRitche, S., Sumner, S., Frost, H. R., et al. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02282-3 · Cited by 80
“pendent methods (Procrustes analysis, SCCA and univariate Spearman correlation), consistent with previous studies on both infant [19, 24] and adult populations [17, 30].”
ResultGounot, J.-S., Chia, M., Bertrand, D., Saw, W., Ravikrishnan, A., Low, A., Ding, Y., Ng, A. H. Q., Tan, L. W. L., Teo, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33782-z · Cited by 74
Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy
Nardone, O. M., Zammarchi, I., Santacroce, G., Ghosh, S., & Iacucci, M. (2023) · Cancers · doi:10.3390/cancers15082389 · Cited by 76
Evaluation of fecal DNA extraction protocols for human gut microbiome studies
Lim, M. Y., Park, Y., Kim, J., & Nam, Y. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01894-5 · Cited by 79
Wang, Z., Bai, Y., Pi, Y., Gerrits, W. J. J., de Vries, S., Shang, L., Tao, S., Zhang, S., Han, D., Zhu, Z., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01175-x · Cited by 71
Feng, L., Zhou, N., Li, Z., Fu, D., Guo, Y., Gao, X., & Liu, X. (2021) · The FASEB Journal · doi:10.1096/fj.202101088rrr · Cited by 72
Niu, M., Guo, H.-X., Cai, J.-W., & Meng, X. (2022) · Nutrients · doi:10.3390/nu14183671 · Cited by 72
Microbiome-phage interactions in inflammatory bowel disease
Federici, S., Kviatcovsky, D., Valdés‐Mas, R., & Elinav, E. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.08.027 · Cited by 81
Encapsulation and delivery of phage as a novel method for gut flora manipulation in situ: A review
Yang, Y., Du, H., Zou, G., Song, Z., Zhou, Y., Li, H., Tan, C. S., Chen, H., Fischetti, V. A., & Li, J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.048 · Cited by 74
Li, M., Liu, J., Zhu, J., Wang, H., Sun, C., Gao, N. L., Zhao, X.-M., & Chen, W.-H. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2205386 · Cited by 66
Compositional Lotka-Volterra describes microbial dynamics in the simplex
Joseph, T., Shenhav, L., Xavier, J. B., Halperin, E., & Pe’er, I. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007917 · Cited by 72
Bacterial Translocation as Inflammatory Driver in Crohn’s Disease
Linares, R., Francés, R., Gutiérrez, A., & Juanola, O. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703310 · Cited by 73
Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD
Noor, N. M., Sousa, P., Paul, S., & Roblin, X. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab228 · Cited by 74
Lamb, C. A., Saifuddin, A., Powell, N., & Rieder, F. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.09.077 · Cited by 72
Wang, L., Gao, M., Kang, G., & Huang, H. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.798038 · Cited by 69
“We also described the latest advances in our understanding of Abbreviations: IBD, inflammatory bowel diseases; UC, ulcerative colitis; CD, Crohn’s disease; MetaHIT, metagenomics of human intestinal tract; NIH, National Institutes of Health; HMP, human microbiome project; iHMP, integrative human microbiome project; NO,…”
BackgroundInfluentialXiao, F., Dong, F., Li, X., Li, Y., Yu, G., Liu, Z., Wang, Y., & Zhang, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.902337 · Cited by 72
Borren, N. Z., Plichta, D. R., Joshi, A. D., Bonilla, G. M., Peng, V., Colizzo, F. P., Luther, J., Khalili, H., Garber, J. J., van der Woude, C. J., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.03.013 · Cited by 71
Self-citationMetabolic interactions in beneficial microbe recruitment by plants
Abedini, D., Jaupitre, S., Bouwmeester, H. J., & Dong, L. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.06.015 · Cited by 70
“For example, transposon-insertion sequencing (TIS) methods, which integrate random mutations in the genome with high-throughput sequencing, have provided a powerful way to investigate microbial gene functions [40,41].”
BackgroundBacterial Species Associated With Human Inflammatory Bowel Disease and Their Pathogenic Mechanisms
Zhang, L., Liu, F., Xue, J., Lee, S. A., Liu, L., & Riordan, S. M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.801892 · Cited by 78
Xu, Q., Wu, C., Zhu, Q. R., Gao, R., Lu, J., Valles‐Colomer, M., Zhu, J., Yin, F., Huang, L., Ding, L., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00193-0 · Cited by 63
Mestre, M. R., Gao, L. A., Shah, S. A., López-Beltrán, A., González-Delgado, A., Martínez‐Abarca, F., Iranzo, J., Redrejo‐Rodríguez, M., Zhang, F., & Toro, N. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac467 · Cited by 72
“To this end, we used a publicly available collection of spacers extracted from 11 817 human gut metagenome datasets (64) and an in-house spacer database that was built by running CRISPRCasFinder (65) on the Integrative Human Microbiome Project – Inflammatory Bowel Disease metagenomic dataset (66) (Methods).”
BackgroundMethodBile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the “Bile Acid Code”
Gadaleta, R. M., Cariello, M., Crudele, L., & Moschetta, A. (2022) · Nutrients · doi:10.3390/nu14153212 · Cited by 65
“This was associated with an enrichment of Roseburia and strongly indicated a lack of BSH-competent bacteria IBD-related dysbiosis [114].”
BackgroundMethodBridging preclinical and clinical gut microbiota research using the ex vivo SIFR® technology
den Abbeele, P. V., Deyaert, S., Thabuis, C., Perreau, C., Bajic, D., Wintergerst, E., Joossens, M., Firrman, J., Walsh, D. M., & Baudot, A. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1131662 · Cited by 75
Tanwar, H., Gnanasekaran, J. M., Allison, D. L., Chuang, L.-S. F., He, X., Aimetti, M., Baima, G., Costalonga, M., Cross, R. K., Sears, C. L., et al. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae028 · Cited by 96
Hayashi, N., Lai, Y., Fuerte-Stone, J., Mimee, M., & Lu, T. K. (2024) · Nature Communications · doi:10.1038/s41467-024-45893-w · Cited by 81
“Additionally, as bacteriophage infection can lead to the HGT of bacterial genes, a genetic fi rewall has been created by the deletion of cellular transfer RNAs and release factor 1 17 .”
Morris, A. H., Meyer, K., & Bohannan, B. J. M. (2020) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2019.0244 · Cited by 74
Li, H., Chen, X., Liu, J., Chen, M., Huang, M. X., Huang, G., Chen, X., Du, Q., Su, J., & Lin, R.-F. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113445 · Cited by 67
Sudhakar, P., Machiels, K., Verstockt, B., Korcsmáros, T., & Vermeire, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.618856 · Cited by 70
“For example, Crohn’s disease, a sub-type of IBD, is characterized by the dysbiosis of the gut microbiome (Joossens et al., 2011; Schaubeck et al., 2016; Shaw et al., 2016).”
BackgroundMicrobiota and body weight control: Weight watchers within?
Boscaini, S., Leigh, S., Lavelle, A., García‐Cabrerizo, R., Lipuma, T., Clarke, G. A., Schellekens, H., & Cryan, J. F. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101427 · Cited by 74
Li, H., Cao, W., Xie, J., Che, H., Liu, L., Dong, X., Song, L., & Xie, W. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119410 · Cited by 67
Resistome expansion in disease-associated human gut microbiomes
Fredriksen, S., de Warle, S., van Baarlen, P., Boekhorst, J., & Wells, J. M. (2023) · Microbiome · doi:10.1186/s40168-023-01610-1 · Cited by 78
Association Between Gut Microbiome and Frailty in the Older Adult Population in Korea
Lim, M. Y., Hong, S. P., Kim, J., & Nam, Y. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa319 · Cited by 72
Chatterjee, I., Zhang, Y., Zhang, J., Lu, R., Xia, Y., & Sun, J. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab044 · Cited by 68
Han, H., Safe, S. H., Jayaraman, A., & Chapkin, R. S. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-043020-090050 · Cited by 75
Tan, M. S., Cheah, P., Chin, A., Looi, L., & Chang, S. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104947 · Cited by 69
Jin, H., Hu, G., Sun, C., Duan, Y., Zhang, Z., Liu, Z., Zhao, X., & Chen, W. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab973 · Cited by 66
Microbial Systems Ecology to Understand Cross-Feeding in Microbiomes
Mataigne, A., Vannier, N., Vandenkoornhuyse, P., & Hacquard, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.780469 · Cited by 72
Zhang, Y., Garrett, S., Carroll, R. E., Xia, Y., & Sun, J. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00502-1 · Cited by 69
“Vitamin D/VDR deficiency has been implicated in patients with inflammatory bowel disease and colon cancer 15–21 .”
Bourgonje, A. R., Andreu‐Sánchez, S., Vogl, T. J., Hu, S., Vila, A. V., Gaćeša, R., Leviatan, S., Kurilshikov, A., Klompus, S., Kalka, I. N., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.04.017 · Cited by 70
Wang, H., Liu, C., Xie, X., Niu, M., Wang, Y., Cheng, X., Zhang, B., Zhang, D., Liu, M., Sun, R., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.05.007 · Cited by 70
Metabolomic epidemiology offers insights into disease aetiology
Fuller, H., Zhu, Y., Nicholas, J. C., Chatelaine, H., Drzymalla, E., Sarvestani, A. K., Julián‐Serrano, S., Tahir, U. A., Sinnott-Armstrong, N., Raffield, L. M., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00903-x · Cited by 69
How Do We Predict a Patient’s Disease Course and Whether They Will Respond to Specific Treatments?
Verstockt, B., Parkes, M., & Lee, J. C. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.245 · Cited by 64
Dietary Patterns and Gut Microbiota: The Crucial Actors in Inflammatory Bowel Disease
He, P., Yu, L., Tian, F., Zhang, H., Chen, W., & Zhai, Q. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac029 · Cited by 71
Xiao, K., Liang, X., Lu, H., Li, X., Zhang, Z., Lu, X., Wang, H., Meng, Y., Roy, A., Luo, W., et al. (2022) · The ISME Journal · doi:10.1038/s41396-022-01247-2 · Cited by 64
“Estimation of microbiome association with serum metabolome Mantel tests were used to quantify the covariation between different measurement types [90].”
MethodThe gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
Xu, X., Ocansey, D. K. W., Hang, S., Wang, B., Amoah, S., Yi, C., Zhang, X., Liu, L., & Mao, F. (2022) · Gut Pathogens · doi:10.1186/s13099-022-00499-9 · Cited by 82
“increasing IBD-associated host-microbial interaction factors [22].”
BackgroundSun, Z., Pan, X., Li, X., Jiang, L., Hu, P., Wang, Y., Ye, Y., Wu, P., Zhao, B., Xu, J., et al. (2023) · Advanced Science · doi:10.1002/advs.202205289 · Cited by 67
Metadata
- Authors
- Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., Casero, D., Courtney, H., Gonzalez, A., Graeber, T. G., Hall, A. B., Lake, K., Landers, C. J., Mallick, H., Plichta, D. R., Prasad, M., Rahnavard, G., Sauk, J., Shungin, D., Vázquez-Baeza, Y., White, R. A., IBDMDB Investigators, Bishai, J., Bullock, K., Deik, A., Dennis, C., Kaplan, J. L., Khalili, H., McIver, L. J., Moran, C. J., Nguyen, L., Pierce, K. A., Schwager, R., Sirota-Madi, A., Stevens, B. W., Tan, W., ten Hoeve, J. J., Weingart, G., Wilson, R. G., Yajnik, V., Braun, J., Denson, L. A., Jansson, J. K., Knight, R., Kugathasan, S., McGovern, D. P. B., Petrosino, J. F., Stappenbeck, T. S., Winter, H. S., Clish, C. B., Franzosa, E. A., Vlamakis, H., Xavier, R. J., & Huttenhower, C.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Broad Institute (US)
- Baylor College of Medicine (US)
- Pacific Northwest National Laboratory (US)
- University of California, Los Angeles (US)
- Cincinnati Children's Hospital Medical Center (US)
- Cedars-Sinai Medical Center (US)
- Emory University (US)
- University of California San Diego (US)
- Washington University in St. Louis (US)
- Corresponding author
- Huttenhower, Curtis
- ORCID
- Arze, Cesar
- Ananthakrishnan, Ashwin N.
- Schirmer, Melanie
- Ajami, Nadim J.
- Bonham, Kevin S.
- Brislawn, Colin J.
- Casero, David
- Graeber, Thomas G.
- Hall, A. Brantley
- Mallick, Himel
- Plichta, Damian R.
- Sauk, Jenny
- Shungin, Dmitry
- Bullock, Kevin
- Deik, Amy
- Khalili, Hamed
- McIver, Lauren J.
- Nguyen, Long
- Pierce, Kerry A.
- Yajnik, Vijay
- Knight, Rob
- McGovern, Dermot P. B.
- Winter, Harland S.
- Clish, Clary B.
- Franzosa, Eric A.
- Vlamakis, Hera
- Xavier, Ramnik J.
- Huttenhower, Curtis
- Venue
- Nature
- Published
- 2019-05-29
- Volume
- 569
- Issue
- 7758
- Pages
- 655-662
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6650278
- OpenAlex
- W2947189704
- Cited by
- 3,143
- References
- 101
- Citations by year
- 2026: 500 · 2025: 555 · 2024: 498 · 2023: 402 · 2022: 441 · 2021: 452 · 2020: 247 · 2019: 42
- FWCI
- 98.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- National Science Foundation (1053486, DEAC05–76RL01830, 76RL01830)
- U.S. Department of Energy (DE-AC05–76RL01830, 76RL01830, AC05-76RL01830, DE-AC05?)
- Battelle (AC05-76RL01830, DE- AC05-76RL01830, DE-AC05)
- Leona M. and Harry B. Helmsley Charitable Trust (P01DK046763, U01DK062413)
- Harvard T.H. Chan School of Public Health
- Crohn's and Colitis Foundation (563526)
- Broad Institute
- Vetenskapsrådet (4.1-2016-00416)
- National Institutes of Health (DBI-1053486, UL1TR001881, DE-AC05-76RL01830)
- National Human Genome Research Institute (R01HG005969)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK046763, R24DK110499, U54DK102557, U01DK062413, P30DK078392, P30DK043351, P30DK040561)
- National Institute of Dental and Craniofacial Research (U54DE023798)
- National Center for Advancing Translational Sciences
- Army Research Office (W911NF-11-1-0473, W911NF, W911NF-11)
- Pacific Northwest National Laboratory (DEAC0576RL01830, 76RL01830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, gut microbiota, dysbiosis, multi-omics, facultative anaerobes, obligate anaerobes, Clostridia, acylcarnitines, bile acids, short-chain fatty acids, serum antibodies, disease activity, temporal variation, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Animals, Fungi, Health, Humans, Phylogeny, Species Specificity, Viruses, Inflammatory Bowel Diseases, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.